Variants of FasL and ABCC5 are predictive of outcome after chemotherapy-based treatment in osteosarcoma

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (81501849, 81201385)
  • Medical Science and Technology Development (ZKX14021)

This publication has 24 references indexed in Scilit: